SEC Form 4 · accession 0001209191-16-152302
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Murray Brennan
Director
Period of report
Nov 25, 2016
Accepted (ET)
Nov 29, 2016 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 25, 2016 | M | 15,000 | $6.49 | A | 59,951 | D | |
| Common StockF1 | Nov 25, 2016 | F | 13,483 | $7.22 | D | 46,468 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $6.49 | Nov 25, 2016 | M | 15,000 | D | — | Dec 13, 2016 | Common Stock | 15,000 | 0 | D |
Explanation of responses
- F1Represents shares withheld to pay the exercise price.
- F25,000 shares previously vested on each of 12/13/07, 12/13/08 and 12/13/09.